Acupuncture in subjects with cold hands sensation: study protocol for a randomized controlled trial by Jung-Chul Seo et al.
TRIALS
Seo et al. Trials 2014, 15:348
http://www.trialsjournal.com/content/15/1/348STUDY PROTOCOL Open AccessAcupuncture in subjects with cold hands
sensation: study protocol for a randomized
controlled trial
Jung-Chul Seo1†, Hyun-jong Lee2†, Min-Ah Kwak3, Sung-Hoon Park1, ImHee Shin4, Woo-Sung Yun5
and Kihyuk Park5*Abstract
Background: Cold hands sensation is a common disorder within the Korean population. Many Korean family
physicians believe that it is a mild early manifestation of Raynaud’s phenomenon (RP), or may be related to RP.
RP is characterized by reversible digital vasospasm provoked by cold temperatures and/or emotional stress, and
doctors often prescribe medications that are used in treatment of RP for subjects with cold hands. However, this
has not shown a clear benefit, and these medications can cause unwanted side effects. It is also reported that
traditional Korean medicine, including acupuncture, is widely used to treat cold hands, although the current level of
evidence for this approach is also poor and to date, there have been no published randomized controlled clinical
trials (RCTs) evaluating the efficacy and safety of acupuncture for cold hands. We have therefore designed a pilot
RCT to obtain information for the design of a further full-scale trial.
Methods/Design: The proposed study is a five-week pilot RCT. A total of 14 subjects will be recruited and randomly
allocated to two groups: an acupuncture plus medication group (experimental group) and a medication-only group
(control group). All subjects will take nifedipine (5 mg once daily) and beraprost (20 mg three times daily) for three
weeks. The experimental group will receive additional treatment with three acupuncture sessions per week for three
weeks (nine sessions total). The primary outcome will be measured using a visual analogue scale. Secondary outcomes
will be measured by blood perfusion in laser Doppler perfusion imaging of the hands, frequency and duration of
episodes of cold hands, and heart rate variability. Assessments will be made at baseline and at one, three, and five
weeks thereafter.
Discussion: This study will provide an indication of the feasibility and a clinical foundation for a future large-scale trial.
Trial registration: This study was registered at Korean Clinical Research Information Service (CRIS) registry on 5 August
2013 with the registration number #KCT0000817.
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One of the normal physiological responses to cold tempera-
tures or emotional stress is a reduction of the skin
temperature to preserve body heat and maintain a normal
body core temperature. Reactions characterized by exces-
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unless otherwise stated.and complaints of cold hands sensation are very common
among the general population [1]. Cold hands sensation is
defined as hands that become intolerably cold when
exposed to normal temperature, in which most individuals
feel no cold. There can be a confusion between cold hands
sensation and Raynaud’s phenomenon (RP), as both have
cold hands as a symptom. The signs of RP include cold and
numb hands when exposed to cold temperatures, with
subsequent pain and skin becoming blue in colour [2]. In a
community-based survey of approximately 7,000 people,
almost 12% responded that they had experienced unusual. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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[3,4]. This may be due to a mild, early manifestation of
Raynaud’s phenomenon (RP) or may be related to RP [1,5],
which is characterized by a reversible digital vasospasm
provoked by cold temperatures and/or emotional stress [6].
A study by Choi et al. [7] found that in South Korea, 43%
of patients with an abnormal cold sensation in the hands or
feet had RP, and that primary RP represented 73% of cases
of RP, and many family physicians prescribe medications
for cold hands sensation based upon treatment recommen-
dations for RP [8].
The exact prevalence of primary RP is unknown. It is
a common disorder, especially in the general practice
setting [9], and its prevalence is thought to be high com-
pared with the low number of patients who seek treat-
ment for it [10]. The treatment is mostly dependent on
the etiology of the disorder and on the presence and se-
verity of the individual symptoms. Lifestyle modifications
including avoidance of cold exposure and caffeine, dis-
continuation of smoking, and sufficient body insulation,
are the first line of treatment for the prevention of
vasospasm [11,12]. If these modifications are insufficient,
calcium channel blockers are the most widely used pharma-
cological agents for treatment [4,13,14], and in severe
forms of RP, prostaglandins, endothelin-1 receptor an-
tagonists, and specific inhibitors of phosphodiesterase-
5 are the treatments of choice [6]. Although a wide
variety of medications are used for treatment of RP,
none have been shown to have a clear benefit, and all
may be associated with unwanted side effects including
headache, flushing, and dizziness. There is currently
no gold standard or universal guideline for the treat-
ment of RP [6,15].
In Korea, traditional treatments including acupuncture
and herbal medications have been widely used to treat
cold hands for many years, and there are a number of
published reports regarding these treatments for cold
hands [16-18]. Nonetheless, the present level of evidence
is poor because of small sample sizes or short durations
of these published studies. In addition, even though
there are a few published randomized controlled trials
(RCT) regarding acupuncture and RP [19,20], there is
no published RCT evaluating the efficacy and safety of
acupuncture in subjects with cold hands sensation.
The need remains for more rigorous studies that will
elucidate the efficacy and safety of acupuncture for
subjects with cold hands sensation. The aim of the
present study was to collect preliminary data on acu-
puncture compared with conventional pharmaceutical
agents alone for the treatment of cold hands sensation.
The results of this study will provide evidence for the
feasibility of this trial design as well as basic data for a
large-scale RCT of acupuncture for subjects with cold
hands sensation.Hypotheses
In this randomized controlled two-arm clinical trial, we
will evaluate the acupuncture treatment as an adjunct
therapy to cold hands sensation. The hypothesis is that
the addition of acupuncture treatment to medication
reduces the severity of cold hands sensation (measured
using a visual analogue scale (VAS)) significantly more
than medications alone.Methods/Design
Design
The study is a randomized controlled pilot clinical trial.
It is designed to obtain basic information of a further
full-scale trial about acupuncture treatment in subjects
with cold hands sensation. The protocols to be used ad-
here to the principles of the Declaration of Helsinki and
have been approved by the Institutional Review Board of
Daegu Catholic University Hospital (approval number
IORG0004453), where the study will take place. The
trial is registered with the Korean Clinical Research
Information Service (CRIS) registry. Written informed
consent will be obtained from each participant before
any treatment is given.
The outcome assessments and statistical analyses will
be performed by professionals blinded to the assign-
ment of subjects. The trial process is presented in
Figure 1. The trial will run for five weeks. Subjects will
be randomly allocated to one of two groups, a control
group, in which subjects will receive only medication
for three weeks, and an experimental group, in which
subjects will receive the same medication as well as
nine acupuncture sessions (three sessions per week for
three weeks). Assessments will be made at baseline and
again at one, three, and five weeks thereafter. The five-
week assessment will be performed two weeks after
treatment cessation. This study will be conducted be-
tween late November 2013 to February 2014 which is
winter season in South Korea. We will record room
temperature to control for temperature bias in this
clinical trial.Recruitment
Participants will be recruited through advertisements
on hospital websites and on bulletin boards. If subjects
are interested in participating, they will be invited to
the hospital for a screening meeting. Eligibility will be
determined by a vascular surgeon based on the results
of physical and photoplethysmography examinations.
If eligible, subjects will be guided through the informed
consent process. After written consent is obtained, a
study researcher will randomly allocate each partici-
pant to one of the two treatment groups.
Identify patients with cold hands sensation
and confirm their eligibility (target number 
of patients = 14)
Randomize the participants
Experimental group (n = 7)
Acupuncture plus medication





nifedipine 5 mg daily 
+ beraprost 20 mg
three times daily
Duration of treatment: 3 weeks
Medication: 
nifedipine 5 mg 
daily + beraprost 20 
mg three times daily
Assess outcomes at baseline and at 1, 3, 
and 5 weeks thereafter
Figure 1 Flow chart of the pilot randomized controlled trial.
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A target sample size of 14 subjects with cold hands sensa-
tion has been set. One of the main objectives of this study
is to provide an estimate of the sample size required for the
full-scale randomized controlled clinical trial.
Inclusion criteria
Participants must meet the following criteria for inclusion
in the study: cold hands sensation or RP, photoplethysmo-
graphy showing decreased arterial pulse amplitude or
abnormal ischemic pulse waveform such as biphasic or
monophasic wave, aged between 20 and 75 years, VAS
score of >3 for cold hands sensation, symptom duration of
least one month, available for follow-up during the entire
trial period, and provide written informed consent.
Exclusion criteria
Participants will be excluded from the study if they meet
any of the following criteria: one or more ulcerated
fingers, acute ischemic disease requiring reperfusion
surgery, high bleeding tendency due to anticoagulant
medications, significant renal or hepatic disease, severe
psychiatric or psychological disorders, known hyper-
sensitivity reaction to acupuncture treatment, alcoholand/or drug abuse, pregnant, lactating, or planning
pregnancy, any individual deemed ineligible by a phys-
ician, refusal to participate in the trial or to provide
informed consent, or an inability to comprehend or
express oneself in the Korean language.Randomization
Subjects will be randomized using a computerized random
number generator by an independent statistician who is
blinded to subject assignment. The method which we use
for randomization concealment is sequentially numbered,
opaque sealed envelopes. Block randomization will be
performed once a participant’s eligibility is confirmed and
written informed consent has been obtained. Treatments
will be scheduled after randomization.Interventions
Subjects will be randomly divided into two treatment
groups: an experimental group (acupuncture plus medi-
cation group) and a control group (medication only
group). The medication will be administered every day
for three weeks and the acupuncture sessions performed
three times per a week for three weeks (nine times in
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bustion, exercises, or lifestyle advice in this study.
Medications
Oral nifedipine (calcium channel blocker, 5 mg once
daily) and beraprost (prostaglandin analog, 20 mg three
times daily) will be prescribed for all subjects in both
groups.
Acupuncture treatment
The following acupoints will be used based on previ-
ously published work [21]: unilateral GV20, bilateral
ST36, PC6, TE5, LI4, and EX-UE9 (extra points). In total,
17 acupoints will be used. Sterilized disposable acupuncture
needles (DongBang Acupuncture Inc., Korea) 0.25 × 40
mm in size will be manually inserted into each of the
acupoints. After needle insertion, the deqi sensation will
be induced by manual stimulation. The needles will be
inserted for 20 ± 5 minutes and then removed. Acupunc-
ture will be practiced by Korea Medical Doctors (KMD)
who are licensed by Ministry of Health and Welfare.
Data collection
In this study, the primary outcome will be measured by
VAS. The secondary outcomes are changes in micro-
vascular blood perfusion, frequency and duration of cold
hands sensation episodes, and heart rate variability
(HRV) measurements. Both primary and secondary out-
comes will be assessed at baseline and at one, three, and
five weeks after initiation of treatment. The treatment
and outcomes measurement schedules are presented in
Table 1.
Primary outcome measurements
VAS The severity of cold hands sensation episodes
ranges across a continuum of values but cannot easily be
measured directly. Therefore, we will use a 10-cm VAS
as the measurement instrument to determine the sever-
ity of cold hands sensation. Each subject will rate each
episode of cold hands sensation on a scale of 0 to 10,
where 0 indicates the absence of the cold hands sensa-









HRV: Heart rate variability, VAS: visual analogue scale.imaginable. VAS measurements will be made at baseline
and at one, three, and five weeks thereafter.
Secondary outcome measurements
Blood perfusion Laser Doppler perfusion imaging (LDPI)
with a Perimed AB LDPI system (Perimed AB, Jaerfaella,
Sweden) will be used to measure the perfusion of microcir-
culation in the skin of the hands. The LDPI system has a
moving laser beam that scans the tissue in steps and a
photo detector that measures the backscattered light. The
frequency shift of the light has a direct relation to the per-
fusion of the lighted area of skin, according to the Doppler
principle [22].
The largest scanning image is 64 × 64 (4096) points and
low, medium, and high resolution modes are available.
The largest scanning area is about 20 × 20 cm. Measur-
ing time is about 50 milliseconds per point, and 4
minutes for a 64 × 64 image. A normal photo is taken
along with the blood perfusion scan in order to localize
the area of interest. When the scan is completed, the
region of interest is selected for analysis of the mean
blood perfusion and its changes using the built-in LDPI
windows 2.5 software.
Frequency and duration of cold hands sensation
episodes The subjects will record the frequency and
duration of each episode of cold hands sensation. The
average frequency and duration of attacks will be calcu-
lated weekly by dividing the total number of attacks and
their duration by the number of a given weekly interval
(observation period). The frequency and duration cold
hands sensation episodes will be measured at baseline
and at one, three, and five weeks thereafter. We will rec-
ord the frequency and duration of cold hands sensation
episodes by patient diaries.
Heart rate variation The pathogenesis of cold hands
sensation is still unclear. Neural and intravascular mech-
anisms are thought to be involved in the pathological
progress. The role of the autonomic nervous system is
most often discussed, with particular attention to sympa-
thetic over-reactivity. HRV analysis is a reliable non-throughout the five-week randomized controlled trial
e Treatment period Follow-up period
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system function [23].
HRV will be measured using a Medicore SA-2000E
analyzer (Medicore Co., Ltd., Seoul, South Korea) with
four limb electrodes. To minimize the influence of con-
founding factors, all subjects were prohibited from using
drugs, caffeine, tobacco, and alcohol for eight hours
before HRV testing. The frequency domain methods of
HRV analysis will be used. Low frequency (LF), high
frequency (HF), LF:HF ratio, LF in normalized units, and
HF in normalized units will be measured. LF reflects the
sympathetic influence, whereas HF reflects the parasym-
pathetic influence. The LF:HF ratio reflects the inter-
action between sympathetic and vagal activity. LF in
normalized units and HF in normalized units are the
respective values of LF and HF divided by the sum of LF
plus HF and multiplied by 100; thus, the sum of LF in
normalized units and HF in normalized units is 100 [24].
HRV measurements will be conducted at baseline and at
one, three, and five weeks thereafter.
Safety
The safety of this trial will be determined by red
blood cell (RBC) count, hemoglobin level, platelet count,
mean corpuscular volume (MCV), mean corpuscular
hemoglobin (MCH) level, mean corpuscular hemoglobin
concentration (MCHC), hematocrit (Hct), total white
blood cell (WBC) count, erythrocyte sedimentation rate
(ESR), aspartate aminotransferase (AST), alanine amino-
transferase (ALT), blood urea nitrogen (BUN), and cre-
atinine level, serum sodium level, serum potassium level,
and serum chloride level. All subjects are evaluated
twice, first at the screening visit and once more after
the termination of acupuncture treatments. To monitor
the safety of the acupuncture treatment, we will monitor
the occurrence of edema, hemorrhage, and pain as adverse
events.
Any reported adverse events will be recorded through-
out the study and vital signs will be monitored at each
visit. The subjects will be asked to voluntarily report
information about adverse events, and the researcher
will confirm the occurrence of adverse events through
methods such as a medical interview. Details about
adverse events, such as the date of occurrence, degree of
severity, causal relationship with the treatment, other
treatments or medications that are suspected to cause
the adverse event, and treatment of the adverse event
will be recorded in detail.
Withdrawal and dropout
All subjects will have the right to withdraw from the
study at any time. Participation will be ended at any
stage if the subject refuses to continue, withdraws con-
sent, or violates the inclusion or exclusion criteria or thetrial protocol. The trial will be stopped if the principal
investigator believes that there are unacceptable risks of
serious adverse events.
Statistical analysis
The statistical significance level will be set at 5%, and
the data will be processed with the last observation car-
ried forward method for the intention-to-treat analysis.
Statistical analysis in this study will be performed using
IBM SPSS Windows version 19.0 statistical software
(IBM Co., Armonk, NY, USA) and will be based on the
Korean Clinical Trial Statistics Guidelines.
The study will identify the comparative equivalence of
demographic variables and clinical characteristics be-
tween the experimental and control groups by perform-
ing the two sample t-test or Mann-Whitney U test if
normality test is satisfied or not for continuous data,
chi-square test for categorical data.
A repeated measure two-factor analysis will be per-
formed to identify differences in VAS, blood perfusion,
frequency and duration of cold hands sensation attacks
and HRV scores between the experimental and control
group based on time (baseline, weeks one, three, and
five). If the interaction between group and time is statis-
tically significant, the point at which the pattern of re-
sults between the two groups changes will be checked
using the contrast analysis. To compare groups and the
incidence frequency of adverse events related to acu-
puncture and medication, the chi-square test will be
used.
Discussion
Cold hands sensation is a common disorder within the
Korean population. In Korea, many physicians believe
the phenomenon is related to RP, and they may pre-
scribe pharmaceutical treatments similar to those used
for patients with RP [5,8]. However, there is no estab-
lished guideline for RP therapy, and many of the agents
most frequently used in the treatment of RP are used
off-label [15] and consist mainly of vasodilators, in par-
ticular calcium channel antagonists such as nifedipine.
While these agents have proven useful in some reports
[14], in about 50% of patients, there is no beneficial
effect [15]. Furthermore, their use has often been associ-
ated with an unacceptably high incidence of side effects
including edema, flushing, erythema, dizziness, nausea,
palpitations, and drowsiness [25,26]. Beraprost is the
first oral prostaglandin analog with vasodilatory and
antiplatelet effects which has been used in the treatment
of RP. To date, one double blind study has indicated that
there was no difference between oral beraprost and pla-
cebo in the treatment of primary RP, and the same study
found that patients in the beraprost group reported a
significantly higher incidence of side effects including
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such as headache, flushing, and diarrhea [15,27]. The
high prevalence of RP in the general population and the
unfavorable side effects profiles of the present medica-
tions further demonstrate the need for alternative treat-
ment options.
Acupuncture is one of the most important compo-
nents of complementary and alternative medicine. It is a
therapy that has been used for thousands of years in
Korea. Recently, there has been increased interest in
the therapeutic benefits of acupuncture [28]. In South
Korea, many subjects with cold hands sensation already
choose traditional Korean medicines such as acupunc-
ture for treatment. However, thus far, there are no pub-
lished controlled clinical trials investigating the efficacy
and safety of acupuncture for treatment of cold hands
sensation. We have therefore designed this pilot RCT to
guide the design of a full-scale trial. Our study will be a
first randomized controlled trial regarding cold hands
sensation, but it has limitation of small sample size. We
expect this pilot study to provide a clinical foundation
for a future large-scale trial as well as information about
the feasibility of such a trial.Trial status
This trial’s recruitment was finished.
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